vs. Teva, Granules & Heritage
Payout Range
Varies
Deadline
7/10/2026
Time Left
2 days
The metformin class action settlement involves claims against Teva Pharmaceuticals, Granules, and Heritage Pharmaceuticals regarding NDMA contamination in their generic metformin products, which were recalled in 2020. The settlement, totaling $5.55 million, aims to compensate consumers and third-party payors who purchased these drugs between July 20, 2015, and June 2, 2020.
No specific eligibility requirements listed. Review the official settlement terms for complete criteria.
Individuals in the United States who purchased, paid for, or provided reimbursement for generic versions of metformin-containing drugs manufactured by Teva, Granules, or Heritage between July 20, 2015 and June 2, 2020.
This settlement has the following claim path.
Claimants must provide proof of at least one purchase of metformin.
This settlement accepts online and mail claim submissions. Pick whichever is easier.
Claims Administrator A.B. Data, Ltd. P.O. Box 17300 Milwaukee, WI 53217
ClaimHawk is an independent service. Review the official settlement site for legally binding terms.